SE348942B - - Google Patents
Info
- Publication number
- SE348942B SE348942B SE763270A SE763270A SE348942B SE 348942 B SE348942 B SE 348942B SE 763270 A SE763270 A SE 763270A SE 763270 A SE763270 A SE 763270A SE 348942 B SE348942 B SE 348942B
- Authority
- SE
- Sweden
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/30—Extraction; Separation; Purification by precipitation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE763270A SE348942B (fr) | 1970-06-02 | 1970-06-02 | |
GB1784271A GB1344340A (en) | 1970-06-02 | 1971-05-28 | Method for fractionating plasma proteins |
NL7107529A NL177599C (nl) | 1970-06-02 | 1971-06-01 | Werkwijze voor het winnen en zuiveren van immunoglobuline g. |
DE19712127159 DE2127159C2 (de) | 1970-06-02 | 1971-06-01 | IgG-Immunglobulinfraktion und ihre Herstellung |
CA114,557A CA960964A (en) | 1970-06-02 | 1971-06-01 | Method for fractionating plasma proteins |
AT471971A AT309678B (de) | 1970-06-02 | 1971-06-01 | Verfahren zur Herstellung von Immunglobulin |
CH793671A CH572745A5 (fr) | 1970-06-02 | 1971-06-01 | |
FR7119993A FR2100716B1 (fr) | 1970-06-02 | 1971-06-02 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE763270A SE348942B (fr) | 1970-06-02 | 1970-06-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
SE348942B true SE348942B (fr) | 1972-09-18 |
Family
ID=20271889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE763270A SE348942B (fr) | 1970-06-02 | 1970-06-02 |
Country Status (8)
Country | Link |
---|---|
AT (1) | AT309678B (fr) |
CA (1) | CA960964A (fr) |
CH (1) | CH572745A5 (fr) |
DE (1) | DE2127159C2 (fr) |
FR (1) | FR2100716B1 (fr) |
GB (1) | GB1344340A (fr) |
NL (1) | NL177599C (fr) |
SE (1) | SE348942B (fr) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010138736A2 (fr) | 2009-05-27 | 2010-12-02 | Baxter International Inc. | Procédé de production d'une préparation d'immunoglobulines hautement concentrée et à usage sous-cutané |
WO2011149472A1 (fr) | 2010-05-26 | 2011-12-01 | Baxter International Inc. | Procédé de préparation d'une composition d'igg enrichie à partir de plasma |
WO2011150284A2 (fr) | 2010-05-26 | 2011-12-01 | Baxter International Inc. | Élimination de sérine protéases par traitement avec du dioxyde de silicium finement divisé |
WO2013033042A1 (fr) | 2011-08-26 | 2013-03-07 | Baxter International Inc. | Procédé pour la réduction du potentiel thromboembolique d'une composition d'immunoglobuline dérivée du plasma |
WO2013126904A1 (fr) | 2012-02-23 | 2013-08-29 | Baxter International Inc. | Précipitation de la fraction i-iv-1 d'immunoglobulines à partir de plasma |
WO2013130826A2 (fr) | 2012-02-29 | 2013-09-06 | Baxter International Inc. | Remyélinisation stimulée par igg de nerfs périphériques |
WO2014134070A1 (fr) | 2013-02-26 | 2014-09-04 | Baxter International Inc. | Traitement des troubles du système nerveux central par administration intranasale d'immunoglobuline g |
WO2014182631A1 (fr) | 2013-05-06 | 2014-11-13 | Baxter International Inc. | Traitement de sous-populations atteintes de la maladie d'alzheimer avec de l'immunoglobuline g rassemblée |
WO2023170553A1 (fr) | 2022-03-07 | 2023-09-14 | Takeda Pharmaceutical Company Limited | Production chromatographique d'affinité de produits igg humains cliniques |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE389596B (sv) * | 1974-06-14 | 1976-11-15 | P G S Lindroos | Saett att ur en vaetska innehallande blodsubstanser separera jaernfoereningar fran globin |
DE2500076C3 (de) * | 1975-01-02 | 1982-11-18 | SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld | Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen |
US4124576A (en) * | 1976-12-03 | 1978-11-07 | Coval M L | Method of producing intravenously injectable gamma globulin |
AT359641B (de) * | 1978-09-19 | 1980-11-25 | Immuno Ag | Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates |
US4315851A (en) * | 1978-12-29 | 1982-02-16 | Kureha Kagaku Kogyo Kabushiki Kaisha | Pharmaceutical composition having antitumor activity |
AU2010205007A1 (en) * | 2009-01-13 | 2011-07-07 | Ge Healthcare Bio-Sciences Ab | Precipitation of biomolecules with negatively charged polymers |
IT1397061B1 (it) * | 2009-12-28 | 2012-12-28 | Kedrion Spa | Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale. |
US8796430B2 (en) | 2010-05-26 | 2014-08-05 | Baxter International Inc. | Method to produce an immunoglobulin preparation with improved yield |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL286954A (fr) * | 1962-01-03 | |||
BE713764A (fr) * | 1967-05-01 | 1968-09-16 | Baxter Travenol Lab | |
AT275038B (de) * | 1967-11-15 | 1969-10-10 | Immuno Ag | Verfahren zur Gewinnung von reinem Blutalbumin aus Hämopigmente enthaltenden Proteinlösungen |
-
1970
- 1970-06-02 SE SE763270A patent/SE348942B/xx unknown
-
1971
- 1971-05-28 GB GB1784271A patent/GB1344340A/en not_active Expired
- 1971-06-01 CA CA114,557A patent/CA960964A/en not_active Expired
- 1971-06-01 DE DE19712127159 patent/DE2127159C2/de not_active Expired
- 1971-06-01 AT AT471971A patent/AT309678B/de active
- 1971-06-01 NL NL7107529A patent/NL177599C/xx not_active IP Right Cessation
- 1971-06-01 CH CH793671A patent/CH572745A5/xx not_active IP Right Cessation
- 1971-06-02 FR FR7119993A patent/FR2100716B1/fr not_active Expired
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3708581A1 (fr) | 2009-05-27 | 2020-09-16 | Baxalta GmbH | Procédé pour produire une préparation d'immunoglobuline hautement concentrée pour usage sous-cutané |
US11242380B2 (en) | 2009-05-27 | 2022-02-08 | Takeda Pharmaceutical Company Limited | Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use |
US8546548B2 (en) | 2009-05-27 | 2013-10-01 | Baxter International Inc. | Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use |
US10125189B2 (en) | 2009-05-27 | 2018-11-13 | Baxalta Incorporated | Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use |
WO2010138736A2 (fr) | 2009-05-27 | 2010-12-02 | Baxter International Inc. | Procédé de production d'une préparation d'immunoglobulines hautement concentrée et à usage sous-cutané |
EP2554160A1 (fr) | 2010-05-26 | 2013-02-06 | Baxter International Inc. | Procédé de préparation d'une composition d'igG enrichie à partir de plasma |
EP4039249A1 (fr) | 2010-05-26 | 2022-08-10 | Baxalta GmbH | Élimination de protéases de sérine par traitement avec du dioxyde de silicium finement divisé |
WO2011150284A2 (fr) | 2010-05-26 | 2011-12-01 | Baxter International Inc. | Élimination de sérine protéases par traitement avec du dioxyde de silicium finement divisé |
US11891431B2 (en) | 2010-05-26 | 2024-02-06 | Takeda Pharm Limited ceutical Company Limited | Removal of serine proteases by treatment with finely divided silicon dioxide |
EP2796128A1 (fr) | 2010-05-26 | 2014-10-29 | Baxter International Inc | Enrichissement du facteur H du plasma |
US10875906B2 (en) | 2010-05-26 | 2020-12-29 | Baxalta Incorporated | Removal of serine proteases by treatment with finely divided silicon dioxide |
EP2803349A1 (fr) | 2010-05-26 | 2014-11-19 | Baxter International Inc. | Procédé de préparation d'une composition d'IgG enrichie de plasma |
US10208106B2 (en) | 2010-05-26 | 2019-02-19 | Baxalta Incorporated | Removal of serine proteases by treatment with finely divided silicon dioxide |
US9708391B2 (en) | 2010-05-26 | 2017-07-18 | Baxalta Incorporated | Removal of serine proteases by treatment with finely divided silicon dioxide |
WO2011149472A1 (fr) | 2010-05-26 | 2011-12-01 | Baxter International Inc. | Procédé de préparation d'une composition d'igg enrichie à partir de plasma |
WO2013033042A1 (fr) | 2011-08-26 | 2013-03-07 | Baxter International Inc. | Procédé pour la réduction du potentiel thromboembolique d'une composition d'immunoglobuline dérivée du plasma |
US9403899B2 (en) | 2011-08-26 | 2016-08-02 | Baxalta Incorporated | Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition |
WO2013126904A1 (fr) | 2012-02-23 | 2013-08-29 | Baxter International Inc. | Précipitation de la fraction i-iv-1 d'immunoglobulines à partir de plasma |
US9782477B2 (en) | 2012-02-23 | 2017-10-10 | Baxalta Incorporated | Fraction I-IV-1 precipitation of immunoglobins from plasma |
EP4119574A1 (fr) | 2012-02-23 | 2023-01-18 | Takeda Pharmaceutical Company Limited | Précipitation de la fraction i-iv-1 d'immunoglobulines à partir de plasma |
WO2013130826A2 (fr) | 2012-02-29 | 2013-09-06 | Baxter International Inc. | Remyélinisation stimulée par igg de nerfs périphériques |
EP3590960A1 (fr) | 2012-02-29 | 2020-01-08 | Baxalta GmbH | Remyélinisation stimulée par igg de nerfs périphériques |
EP3597220A1 (fr) | 2013-02-26 | 2020-01-22 | Baxalta GmbH | Traitement de maladies du système nerveux central par l'administration intranasal d'immunoglobulines g |
WO2014134070A1 (fr) | 2013-02-26 | 2014-09-04 | Baxter International Inc. | Traitement des troubles du système nerveux central par administration intranasale d'immunoglobuline g |
EP3552624A1 (fr) | 2013-05-06 | 2019-10-16 | Baxalta Incorporated | Traitement des sous-populations de la maladie d'alzheimer avec l'immunoglobuline g groupée |
WO2014182631A1 (fr) | 2013-05-06 | 2014-11-13 | Baxter International Inc. | Traitement de sous-populations atteintes de la maladie d'alzheimer avec de l'immunoglobuline g rassemblée |
WO2023170553A1 (fr) | 2022-03-07 | 2023-09-14 | Takeda Pharmaceutical Company Limited | Production chromatographique d'affinité de produits igg humains cliniques |
Also Published As
Publication number | Publication date |
---|---|
NL177599B (nl) | 1985-05-17 |
DE2127159C2 (de) | 1981-12-24 |
CA960964A (en) | 1975-01-14 |
CH572745A5 (fr) | 1976-02-27 |
AT309678B (de) | 1973-08-27 |
FR2100716A1 (fr) | 1972-03-24 |
DE2127159A1 (de) | 1971-12-09 |
NL177599C (nl) | 1985-10-16 |
FR2100716B1 (fr) | 1975-06-06 |
NL7107529A (fr) | 1971-12-06 |
GB1344340A (en) | 1974-01-23 |